Figure 3 — The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker

Research Paper|Volume 15, Issue 6|pp. 2136–2157

The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker

Back to articleFigure 3(3 of 6)

100%

Figure 3.Enrichment analysis of CDKN2A marker gene set in pan-cancer. The circle size represents the FDR value of the enrichment term about each cancer. The color signifies the normalized enrichment score (NES).